Gelatin Sponge market will grow at highest pace owing to rise in surgical procedures

Gelatin Sponge market will grow at highest pace owing to rise in surgical procedures

Gelatin sponges help control bleeding and absorb fluids from wounds. They are easy to use, provide fast hemostasis and help maintain a dry surgical field. Gelatin sponges come pre-cut or as sheets that can be cut or shaped as needed during surgery. Their porous structure allows fluids and blood to pass through and be absorbed while platelets can stick inside the sponge and form clots to stop bleeding.

The global gelatin sponge market is estimated to be valued at US$ 235.9 million in 2024 and is expected to exhibit a CAGR of 6.4% over the forecast period from 2024 to 2031.

Key Takeaways
Key players operating in the gelatin sponge market are Pfizer Inc., B. Braun SE, GELITA MEDICAL, CuraMedical B.V., Aegis Lifesciences, Angellifescience, EON Meditech, GOODWILL LIFESCIENCES PVT. LTD, Mil Laboratories Pvt. Ltd., EUCARE PHARMACEUTICALS (P) LTD. Pfizer Inc. dominates the global gelatin sponge market with its Surgicel brand. The rising number of surgical procedures across the world is driving the demand for hemostatic agents. Advancements in surgical techniques and instruments have made complex surgeries more accessible and common. Technological advancements are also helping manufacturers develop advanced wound management solutions.

Market trends
The Gelatin Sponge Market Size  is witnessing increasing adoption of local wound hemostatic agents (LWHAs) over traditional compression methods. LWHAs like gelatin sponges provide direct and fast hemostasis at the bleeding site rather than indirect hemostasis through compression. Another trend is manufacturers developing gelatin sponges and other hemostatic products specifically for pediatric surgeries which often require very localized hemostasis due to small wound sizes.

Market Opportunities
One of the key opportunities for gelatin sponge manufacturers is the rising surgical volumes in developing countries. As access to healthcare and affordability of surgeries increases in emerging economies, the number of surgical procedures will witness strong growth over the next decade. Another growth avenue is the development of advanced hemostatic wound management solutions through technological innovation. Players are exploring strategies like combination technologies to develop next-gen products.

Impact of COVID-19 on Gelatin Sponge Market Growth

The COVID-19 pandemic has significantly impacted the growth of the gelatin sponge market. During the initial months of the pandemic, restrictions on non-essential surgical procedures led to declining demand for gelatin sponges in the healthcare sector. As gelatin sponges are primarily used during surgical procedures to control bleeding or absorb fluids, their usage reduced substantially due to the postponement of elective surgeries. However, with growing demand for healthcare resources during the pandemic, the usage of gelatin sponges increased for COVID-19 related medical procedures. Some key ways in which the pandemic has affected the market include increased Research & Development activities to develop advanced wound healing and hemostatic products, supply chain disruptions causing raw material shortage and price volatility, and growing preference for local manufacturers to avoid dependency on imports. Looking ahead, rising surgical volume as restrictions ease and increased focus on infection control are expected to support the market recovery in the post-COVID era. Companies will need to focus on new product development, establish efficient distribution networks and ensure continued supplies to pre-pandemic levels to capitalize on future opportunities.

In terms of value, North America accounted for the largest share of the gelatin sponge market in 2021, owing to the rising geriatric population, growing prevalence of chronic diseases, favourable reimbursement policies and rapid uptake of advanced surgical technologies. However, Asia Pacific is expected to witness the fastest growth during the forecast period due to improving access to healthcare facilities, rising medical tourism and increasing patient affordability in the region. Factors such as large patient pool, growing incidence of traumatic injuries, and increasing investments by market players are driving the demand for gelatin sponges in Asia Pacific countries like China and India.

Europe also represents a major geographical region for the gelatin sponge market. This is attributed to the presence of a well-established healthcare infrastructure, high awareness about new medical technologies, and government support for research & innovation in the region. However, market growth is likely to be negatively impacted due to budgetary constraints and economic uncertainties arising due to the COVID-19 pandemic in some European countries.

Get more insights on – Gelatin Sponge market

About Author:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)